-
-
[1] Fiorina P, Shapiro A, Ricordi C, et al. The clinical impact of islet transplantation[J]. Am J Transplantat, 2008, 8:1990-1997. doi: 10.1111/j.1600-6143.2008.02353.x [2] Robertson RP, Davis C, Larsen J, et al. Pancreas and islet transplantation in type 1 diabetes[J]. Diabetes Care, 2006, 29:935. doi: 10.2337/diacare.29.04.06.dc06-9908 [3] Ballinger W, Lacy P. Transplantation of intact pancreatic islets in rats[J]. Surgery, 1972, 72:175. http://europepmc.org/abstract/MED/4262169 [4] Brendel MD, Hering BJ, Schultz AO, et al. International islet transplant registry report[R/OL]. (1999-08-22)[2013-04-15]. http://www.med.uni-giessen.de/itr/newsletter/newsletter.htm. [5] Shapiro AJ, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen[J]. New Engl J Med, 2000, 343:230-238. doi: 10.1056/NEJM200007273430401 [6] Shapiro AJ, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation[J]. New Engl J Med, 2006, 355:1318-1330. doi: 10.1056/NEJMoa061267 [7] Alejandro R, Barton FB, Hering BJ, et al. 2008 Update from the collaborative islet transplant registry[J]. Transplantation, 2008, 86:1783-1788. doi: 10.1097/TP.0b013e3181913f6a [8] Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation:1999-2010[J]. Diabetes Care, 2012, 35:1436-1445. doi: 10.2337/dc12-0063 [9] Deters NA, Stokes RA, Gunton JE. Islet transplantation:factors in short-term islet survival[J]. Arch Immunol Ther Exp, 2011, 59:421-429. doi: 10.1007/s00005-011-0143-0 [10] Shapiro AJ. State of the art of clinical islet transplantation and novel protocols of immunosuppression[J]. Curr Diab Rep, 2011, 11:345-354. doi: 10.1007/s11892-011-0217-8 [11] Jung HS, Choi SH, Kim SJ, et al. A better yield of islet cell mass from living pancreatic donors compared with cadaveric donors[J]. Clin Transplant, 2007, 21:738-743. http://www.ingentaconnect.com/content/mksg/ctr/2007/00000021/00000006/art00009 [12] Hirshberg B. Can we justify living donor islet transplantation?[J]. Curr Diab Rep, 2006, 6:307-309. doi: 10.1007/s11892-006-0065-0 [13] Groth C, Tibell A, Tollemar J, et al. Transplantation of porcine fetal pancreas to diabetic patients[J]. Lancet, 1994, 344:1402-1404. doi: 10.1016/S0140-6736(94)90570-3 [14] Heneine W, Tibell A, Switzer WM, et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts[J]. Lancet, 1998, 352:695-698. doi: 10.1016/S0140-6736(98)07145-1 [15] Grose S. Critics slam Russian trial to test pig pancreas for diabetics[J]. Nat Med, 2007, 13:390-391. http://www.onacademic.com/detail/journal_1000034764192510_d476.html [16] Narushima M, Kobayashi N, Okitsu T, et al. A human β-cell line for transplantation therapy to control type 1 diabetes[J]. Nat Biotechnol, 2005, 23:1274-1282. doi: 10.1038/nbt1145 [17] Ravassard P, Hazhouz Y, Pechberty S, et al. A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion[J]. J Clin Invest, 2011, 121:3589. doi: 10.1172/JCI58447 [18] Kroon E, Martinson LA, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo[J]. Nat Biotechnol, 2008, 26:443-452. doi: 10.1038/nbt1393 [19] D'Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells[J]. Nat Biotechnol, 2006, 24:1392-1401. doi: 10.1038/nbt1259 [20] Kahan BW, Jacobson LM, Hullett DA, et al. Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells an in vitro model to study islet differentiation[J]. Diabetes, 2003, 52:2016-2024. doi: 10.2337/diabetes.52.8.2016 [21] McCall M, Toso C, Baetge E, et al. Are stem cells a cure for diabetes?[J]. Clin Sci, 2010, 118:87-97. doi: 10.1042/CS20090072 [22] Domínguez-Bendala J, Lanzoni G, Inverardi L, et al. Concise review:mesenchymal stem cells for diabetes[J]. Stem Cells Transl Med, 2012, 1:59-63. doi: 10.5966/sctm.2011-0017 [23] Reading JL, Sabbah S, Busch S, et al. Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation[J]. Curr Opin Organ Transplant, 2013, 18:59-64. doi: 10.1097/MOT.0b013e32835c2adf [24] Tang DQ, Wang Q, Burkhardt BR, et al. In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long-term culture running risk of malignanttransformation[J]. Am J Stem Cells, 2012, 1:114. http://labs.europepmc.org/abstract/PMC/PMC3402040/reload=0%3Bjsessionid=FXGXNALxeTd1pakNSwBV.50 [25] Vija L, Farge D, Gautier JF, et al. Mesenchymal stem cells:stem cell therapy perspectives for type 1 diabetes[J]. Diabetes Metab, 2009, 35:85-93. doi: 10.1016/j.diabet.2008.10.003 [26] Lv S, Cheng J, Sun A, et al. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress[J]. Diabetes Res Clin Pract, 2014, 104:143-154. doi: 10.1016/j.diabres.2014.01.011 [27] Wang S, Li Y, Zhao J, et al. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model[J]. Biol Blood Marrow Transplant, 2013, 19:538-546. doi: 10.1016/j.bbmt.2013.01.001 [28] Yang Z, Li K, Yan X, et al. Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats[J]. Graefes Arch Clin Exp Ophthalmol, 2010, 248:1415-1422. doi: 10.1007/s00417-010-1384-z [29] Kuo YR, Wang CT, Cheng JT, et al. Bone marrow-derived mesenchymal stem cells enhanced diabetic wound healing through recruitment of tissue regeneration in a rat model of streptozotocin-induced diabetes[J]. Plast Reconstr Surg, 2011, 128:872-880. doi: 10.1097/PRS.0b013e3182174329 [30] Maharlooei MK, Bagheri M, Solhjou Z, et al. Adipose tissue derived mesenchymal stem cell (AD-MSC) promotes skin wound healing in diabetic rats[J]. Diabetes Res Clin Pract, 2011, 93:228-234. doi: 10.1016/j.diabres.2011.04.018 [31] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126:663-676. doi: 10.1016/j.cell.2006.07.024 [32] Alipio Z, Liao W, Roemer EJ, et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic β-like cells[J]. Proc Natl Acad Sci USA, 2010, 107:13426-13431. doi: 10.1073/pnas.1007884107 [33] Stadtfeld M, Nagaya M, Utikal J, et al. Induced pluripotent stem cells generated without viral integration[J]. Science, 2008, 322:945-949. doi: 10.1126/science.1162494 [34] Golestaneh N, Kokkinaki M, Pant D, et al. Pluripotent stem cells derived from adult human testes[J]. Stem Cells Dev, 2009, 18:1115-1125. doi: 10.1089/scd.2008.0347 [35] Kobayashi T, Yamaguchi T, Hamanaka S, et al. Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells[J]. Cell, 2010, 142:787-799. doi: 10.1016/j.cell.2010.07.039 [36] Ber I, Shternhall K, Perl S, et al. Functional, persistent, and extended liver to pancreas transdifferentiation[J]. J Biol Chem, 2003, 278:31950-31957. doi: 10.1074/jbc.M303127200 [37] Yang LJ. Liver stem cell-derived β-cell surrogates for treatment of type 1 diabetes[J]. Autoimmun Rev, 2006, 5:409-413. doi: 10.1016/j.autrev.2005.10.009 [38] Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells[J]. Nature, 2008, 455:627-632. doi: 10.1038/nature07314 [39] Yang YP, Thorel F, Boyer DF, et al. Context-specific α-to-β-cell reprogramming by forced Pdx1 expression[J]. Genes Dev, 2011, 25:1680-1685. doi: 10.1101/gad.16875711 [40] Wang R, Klöppel G, Bouwens L. Duct-to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats[J]. Diabetologia, 1995, 38:1405-1411. doi: 10.1007/BF00400600 [41] Dor Y, Brown J, Martinez OI, et al. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation[J]. Nature, 2004, 429:41-46. doi: 10.1038/nature02520 [42] Furuyama K, Kawaguchi Y, Akiyama H, et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine[J]. Nat Genet, 2011, 43:34-41. doi: 10.1038/ng.722
点击查看大图
计量
- 文章访问数: 109
- HTML全文浏览量: 34
- PDF下载量: 5
- 被引次数: 0